A controversial bankruptcy plan involving Purdue Pharma, which would shield the Sackler family from litigation tied to the opioid crisis, has moved forward.
A controversial bankruptcy plan involving Purdue Pharma, which would shield the Sackler family from litigation tied to the opioid crisis, has moved forward.
Please to comment